Novo Nordisk Aktie
| 41,24EUR | -0,37EUR | -0,88% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Barclays Capital | 340,00DKK | 9,47% | 13.02.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 360,00DKK | 15,90% | 12.02.26 | |||
| Jefferies & Company Inc. | 275,00DKK | -11,46% | 12.02.26 | |||
| Deutsche Bank AG | 400,00DKK | 28,78% | 11.02.26 | |||
| UBS AG | 332,00DKK | 6,89% | 06.02.26 | |||
| JP Morgan Chase & Co. | 350,00DKK | 12,69% | 06.02.26 | |||
| Goldman Sachs Group Inc. | 436,00DKK | 40,37% | 22.01.26 | |||
| Bernstein Research | 540,00DKK | 73,86% | 07.11.25 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|